Prolactinoma differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 12: | Line 12: | ||
#'''[[Physiological]]:''' | #'''[[Physiological]]:''' | ||
#*Normal [[pregnancy]]<ref name="pmid910825">{{cite journal| author=Rigg LA, Lein A, Yen SS| title=Pattern of increase in circulating prolactin levels during human gestation. | journal=Am J Obstet Gynecol | year= 1977 | volume= 129 | issue= 4 | pages= 454-6 | pmid=910825 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=910825 }} </ref> | #*Normal [[pregnancy]]<ref name="pmid910825">{{cite journal| author=Rigg LA, Lein A, Yen SS| title=Pattern of increase in circulating prolactin levels during human gestation. | journal=Am J Obstet Gynecol | year= 1977 | volume= 129 | issue= 4 | pages= 454-6 | pmid=910825 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=910825 }} </ref> | ||
#'''[[Pathological]]:'''[[Pituitary tumors]] (other than prolactinoma):<ref name="pmid15316045">{{cite journal| author=Levy A| title=Pituitary disease: presentation, diagnosis, and management. | journal=J Neurol Neurosurg Psychiatry | year= 2004 | volume= 75 Suppl 3 | issue= | pages= iii47-52 | pmid=15316045 | doi=10.1136/jnnp.2004.045740 | pmc=1765669 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15316045 }} </ref> | #'''[[Pathological]]:'''[[Pituitary tumors]] (other than [[prolactinoma]]):<ref name="pmid15316045">{{cite journal| author=Levy A| title=Pituitary disease: presentation, diagnosis, and management. | journal=J Neurol Neurosurg Psychiatry | year= 2004 | volume= 75 Suppl 3 | issue= | pages= iii47-52 | pmid=15316045 | doi=10.1136/jnnp.2004.045740 | pmc=1765669 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15316045 }} </ref> | ||
#*[[Somatotroph adenoma]]: [[Acromegaly]] | #*[[Somatotroph adenoma]]: [[Acromegaly]] | ||
#*[[ACTH-secreting tumor|Corticotroph adenoma]]: [[Cushing's syndrome]] | #*[[ACTH-secreting tumor|Corticotroph adenoma]]: [[Cushing's syndrome]] | ||
#*Supra [[Sella turcica|seller]] tumors(tumors present in region of [[pituitary stalk]]) | #*Supra [[Sella turcica|seller]] tumors(tumors present in region of [[pituitary stalk]]) | ||
#*[[Hypothyroidism]]<ref name="pmid4199418">{{cite journal| author=Snyder PJ, Jacobs LS, Utiger RD, Daughaday WH| title=Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone. | journal=J Clin Invest | year= 1973 | volume= 52 | issue= 9 | pages= 2324-9 | pmid=4199418 | doi=10.1172/JCI107421 | pmc=333037 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4199418 }} </ref> | #*[[Hypothyroidism]]<ref name="pmid4199418">{{cite journal| author=Snyder PJ, Jacobs LS, Utiger RD, Daughaday WH| title=Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone. | journal=J Clin Invest | year= 1973 | volume= 52 | issue= 9 | pages= 2324-9 | pmid=4199418 | doi=10.1172/JCI107421 | pmc=333037 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4199418 }} </ref> | ||
Line 34: | Line 33: | ||
#**[[Verapamil]]<ref name="pmid6682619">{{cite journal| author=Fearrington EL, Rand CH, Rose JD| title=Hyperprolactinemia-galactorrhea induced by verapamil. | journal=Am J Cardiol | year= 1983 | volume= 51 | issue= 8 | pages= 1466-7 | pmid=6682619 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6682619 }} </ref> | #**[[Verapamil]]<ref name="pmid6682619">{{cite journal| author=Fearrington EL, Rand CH, Rose JD| title=Hyperprolactinemia-galactorrhea induced by verapamil. | journal=Am J Cardiol | year= 1983 | volume= 51 | issue= 8 | pages= 1466-7 | pmid=6682619 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6682619 }} </ref> | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="4" |Prolactinoma must be differentiated from causes of hyperprolactinemia | |||
|- | |||
!Disease | !Disease | ||
!Clinical Findings | !Clinical Findings | ||
Line 123: | Line 124: | ||
|- | |- | ||
|[[Chronic renal failure]] | |[[Chronic renal failure]] | ||
|There are no pathognomonic symptoms associated with chronic renal failure. Common non-specific symptoms of chronic renal failure | |There are no pathognomonic symptoms associated with chronic renal failure. Common non-specific symptoms of chronic renal failure includes: | ||
* [[Malaise]] | * [[Malaise]] | ||
* [[nausea]] | * [[nausea]] | ||
Line 130: | Line 131: | ||
* [[lower extremity edema]] | * [[lower extremity edema]] | ||
* [[sleep disorders]] | * [[sleep disorders]] | ||
|[[ | |[[Urinalysis]]: | ||
* [[Albuminuria]] | |||
* [[Hematuria]] | |||
* [[Pyuria]] | |||
* Red cell or white cell [[casts]] and crystals | |||
Fluid and Electrolyte disturbances: | |||
* [[Hyponatremia]] | |||
* [[Hyperkalemia]] | |||
* [[Hyperphosphatemia]] | |||
* [[Hyperchloremia]] | |||
* [[Metabolic acidosis]] | |||
* [[Hypocalcemia]] | |||
Endocrine and Metabolic disturbances | |||
* [[Hyperuricemia]] | |||
* [[Hypertriglyceridemia]] | |||
* Decreased [[HDL]] levels | |||
* [[Vitamin D deficiency]] | |||
* Increased [[Parathyroid hormone]] levels | |||
Hematologic abnormalities | |||
* [[Normocytic normochromic anemia]] | |||
* [[Lymphocytopenia]] | |||
* [[Leukopenia]] | |||
* [[Thrombocytopenia]] | |||
| | | | ||
* Medical management: | * Medical management: | ||
Line 142: | Line 167: | ||
** [[Kidney transplant]] | ** [[Kidney transplant]] | ||
|- | |- | ||
|[[Cirrhosis]] | |[[Cirrhosis|Liver disease: Cirrhosis]] | ||
| | |The clinical features of liver cirrhosis are very non-specific. These includes: | ||
|[[ | * Right upper quadrant [[abdominal pain]] | ||
| | * [[Fever]] | ||
* [[Fatigue]] and [[weakness]] | |||
* [[Loss of appetite]] | |||
* [[Diarrhea]] | |||
* [[Nausea]] and [[vomiting]] | |||
* [[Weight loss]] | |||
* [[Abdominal pain]] and bloating when fluid accumulates in the abdomen | |||
* [[Itching]] | |||
* Menstrual irregularities | |||
|Elevated [[aminotransferases]] ([[Aspartate transaminase|AST]] & [[Alanine transaminase|ALT]]) | |||
Elevated [[alkaline phosphatase]] ([[Alkaline phosphatase|ALP]]) | |||
Elevated [[gamma-glutamyl transpeptidase]] | |||
Elevated [[bilirubin]] | |||
Low [[albumin]] | |||
Elevated [[prothrombin time]] | |||
Elevated [[globulin]] | |||
[[Hyponatremia]] | |||
[[Anemia]] | |||
[[Leukopenia]] and [[neutropenia]] | |||
[[Thrombocytopenia]] | |||
| | | | ||
* Medical management: | |||
** Treatment is directed directed most of the times towards the treatment of complications like [[ascites]], [[esophageal varices]], [[hepatic encephalopathy]], [[hepatorenal syndrome]], [[spontaneous bacterial peritonitis]]. | |||
*** Some chronic constitutional symptoms that should be treated includes: | |||
**** [[Pruritis]]: [[Cholestyramine]] is the drug of choice | |||
**** [[Hypogonadism]]: Topical [[testosterone]] preparations | |||
**** [[Osteoporosis]]: [[Calcium]] and [[vitamin D]] | |||
**** Pain management: [[Non-steroidal anti-inflammatory drug|NSAIDS]], [[celecoxib]], [[opioids]] | |||
**** Nutrition: Adequate calories, proteins and multivitamin supplementation | |||
* Surgical management: [[Liver transplantation]] | |||
|- | |- | ||
|[[Seizure|Seizure disorder]] | |[[Seizure|Seizure disorder]] | ||
| | |The clinical feature of [[seizure disorder]] includes: | ||
* Change in [[alertness]]; the person cannot remember a period of time | |||
* Mood changes, such as unexplainable fear, panic, joy, or laughter | |||
* Change in sensation of the skin, usually spreading over the arm, leg, or trunk | |||
* [[Vision]] changes, including seeing flashing lights | |||
* Rarely, [[Hallucination|hallucinations]] (seeing things that aren't there) | |||
* Falling, loss of muscle control, occurs very suddenly | |||
* [[Muscle twitching]] that may spread up or down an arm or leg | |||
* Muscle tension or tightening that causes twisting of the body, head, arms, or legs | |||
* Shaking of the entire body | |||
* Tasting a bitter or metallic flavor | |||
|[[Electroencephalogram]] | |[[Electroencephalogram]] | ||
| | | | ||
* Medical management: | |||
** [[Antiepileptics|Antiepileptic]] medications | |||
|- | |||
|[[Medication-induced]] | |||
|Clinical features of [[hyperprolactinemia]] after a specific period of regular medication ingestion | |||
|Stop the medication and see if symptoms resolve | |||
|Change to alternate medication | |||
|} | |} | ||
Revision as of 18:57, 20 July 2017
Prolactinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Prolactinoma differential diagnosis On the Web |
American Roentgen Ray Society Images of Prolactinoma differential diagnosis |
Risk calculators and risk factors for Prolactinoma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
Prolactinoma must be differentiated from other causes of hyperprolactinemia.
Causes of hyperprolactinemia can be categorized as physiological, pathological and medication-induced.
Differential Diagnosis
Prolactinoma must be differentiated from other causes of hyperprolactinemia including:
- Physiological:
- Pathological:Pituitary tumors (other than prolactinoma):[2]
- Somatotroph adenoma: Acromegaly
- Corticotroph adenoma: Cushing's syndrome
- Supra seller tumors(tumors present in region of pituitary stalk)
- Hypothyroidism[3]
- Chronic renal failure[4]
- Liver disease[5]
- Cirrhosis(with or without encephalopathy)
- Viral hepatitis(with encephalopathy)
- Seizure disorder[6]
- Medication-induced:
- Antipsychotic medications:[7]
- Antiemetic medications:
- Antihypertensive medications:
Prolactinoma must be differentiated from causes of hyperprolactinemia | |||
---|---|---|---|
Disease | Clinical Findings | Laboratory findings | Management |
Somatotroph adenoma: | Clinical features of acromegaly are due to high level of human growth hormone(hGH):
|
|
|
Corticotroph adenoma: Cushing's syndrome | Clinical features of Cushing's syndrome are due to increased level of cortisol:
|
|
|
Hypothyroidism | Clinical features of hypothyroidism are due to deficiency of thyroxine:
|
Levothyroxine | |
Chronic renal failure | There are no pathognomonic symptoms associated with chronic renal failure. Common non-specific symptoms of chronic renal failure includes:
|
Urinalysis:
Fluid and Electrolyte disturbances: Endocrine and Metabolic disturbances
Hematologic abnormalities |
|
Liver disease: Cirrhosis | The clinical features of liver cirrhosis are very non-specific. These includes:
|
Elevated aminotransferases (AST & ALT)
Elevated alkaline phosphatase (ALP) Elevated gamma-glutamyl transpeptidase Elevated bilirubin Low albumin Elevated prothrombin time Elevated globulin |
|
Seizure disorder | The clinical feature of seizure disorder includes:
|
Electroencephalogram |
|
Medication-induced | Clinical features of hyperprolactinemia after a specific period of regular medication ingestion | Stop the medication and see if symptoms resolve | Change to alternate medication |
References
- ↑ Rigg LA, Lein A, Yen SS (1977). "Pattern of increase in circulating prolactin levels during human gestation". Am J Obstet Gynecol. 129 (4): 454–6. PMID 910825.
- ↑ Levy A (2004). "Pituitary disease: presentation, diagnosis, and management". J Neurol Neurosurg Psychiatry. 75 Suppl 3: iii47–52. doi:10.1136/jnnp.2004.045740. PMC 1765669. PMID 15316045.
- ↑ Snyder PJ, Jacobs LS, Utiger RD, Daughaday WH (1973). "Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone". J Clin Invest. 52 (9): 2324–9. doi:10.1172/JCI107421. PMC 333037. PMID 4199418.
- ↑ Sievertsen GD, Lim VS, Nakawatase C, Frohman LA (1980). "Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure". J Clin Endocrinol Metab. 50 (5): 846–52. doi:10.1210/jcem-50-5-846. PMID 7372775.
- ↑ Jha SK, Kannan S (2016). "Serum prolactin in patients with liver disease in comparison with healthy adults: A preliminary cross-sectional study". Int J Appl Basic Med Res. 6 (1): 8–10. doi:10.4103/2229-516X.173984. PMC 4765284. PMID 26958514.
- ↑ Ben-Menachem, Elinor (2006). "Is Prolactin a Clinically Useful Measure of Epilepsy?". Epilepsy Currents. 6 (3): 78–79. doi:10.1111/j.1535-7511.2006.00104.x. ISSN 1535-7597.
- ↑ David SR, Taylor CC, Kinon BJ, Breier A (2000). "The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia". Clin Ther. 22 (9): 1085–96. doi:10.1016/S0149-2918(00)80086-7. PMID 11048906.
- ↑ McCallum RW, Sowers JR, Hershman JM, Sturdevant RA (1976). "Metoclopramide stimulates prolactin secretion in man". J Clin Endocrinol Metab. 42 (6): 1148–52. doi:10.1210/jcem-42-6-1148. PMID 777023.
- ↑ Sowers JR, Sharp B, McCallum RW (1982). "Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man". J Clin Endocrinol Metab. 54 (4): 869–71. doi:10.1210/jcem-54-4-869. PMID 7037817.
- ↑ Steiner J, Cassar J, Mashiter K, Dawes I, Fraser TR, Breckenridge A (1976). "Effects of methyldopa on prolactin and growth hormone". Br Med J. 1 (6019): 1186–8. PMC 1639736. PMID 1268617.
- ↑ Fearrington EL, Rand CH, Rose JD (1983). "Hyperprolactinemia-galactorrhea induced by verapamil". Am J Cardiol. 51 (8): 1466–7. PMID 6682619.